Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prostate Artery Embolization for Lower Urinary Tract Symptoms in Men Unfit for Surgery

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lyme Neuroborreliosis in a Patient with Breast Cancer: MRI and PET/CT Findings

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diagnostics Receives First Impact Factor

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hand-Held Ultrasound Devices Compared with High-End Ultrasound Systems: A Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pressure Difference Estimation in Carotid Bulbs using Vector Flow Imaging - A Phantom Study

    Research output: Contribution to journalConference articleResearchpeer-review

View graph of relations

Nearly one in three men develop lower urinary tract symptoms (LUTS) and 10% clinically progress despite medication. Transurethral resection of the prostate (TURP) is the reference standard for symptoms refractory to medical treatment. However, some patients cannot tolerate TURP for medical (e.g., comorbidity) or technical (e.g., large prostate) reasons. This study estimated the safety and effect of prostate artery embolization (PAE) in men unfit for surgery. A prospective, single-centre trial including men with LUTS or urinary retention secondary to benign prostatic hyperplasia (BPH) who were unfit for surgery. The primary objective was to treat urinary retention and LUTS. Outcome measures included International Prostate Symptom Score (IPSS), quality of life (IPSS-QoL), International Index of Erectile Function (IIEF-5), prostate volume (PV), prostate-specific antigen (PSA), peak void flow (Qmax), post-void residual (PVR), and complications. A p-value < 0.05 was considered statistically significant. Eleven consecutive patients with a mean age of 75.2 (SD ± 8.2) underwent PAE. Catheter removal was successful in 60%. IPSS-QoL improved 4.5 points (95% CI: -5.6; -3.4), and PV was reduced by 26.2 cm3 (95% CI: -50.9; -2.3). None of the remaining outcomes changed. No major complications occurred. PAE was effective and safe for LUTS and urinary retention associated with BPH in men unfit for surgery.

Original languageEnglish
JournalDiagnostics
Volume9
Issue number2
Pages (from-to)46
ISSN2075-4418
DOIs
Publication statusPublished - 1 Jan 2019

    Research areas

  • Clinical trial, Embolization, Interventional, Lower urinary tract symptoms, Prostatic hyperplasia, Radiology, Therapeutic, Urinary retention

ID: 57104007